UK's Minister For Universities And Science, David Willetts & His Delegation Visit Pluristem Therapeutics Regarding UK-Israel Cooperation On Regenerative Medicine
Published: Mar 26, 2014
HAIFA, Israel, March 26, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that a delegation from the UK made an official visit to Pluristem on March 25, 2014. Officials visiting Pluristem included the UK's Minister for Universities and Science, David Willetts, whose responsibilities include overseeing the Department of Business Innovation and Skills (BIS), and Dr. Stephen Ward, Chief Operating Officer of the Cell Therapy Catapult, a non-profit organization which aims to grow the UK cell therapy industry.
Help employers find you! Check out all the jobs and post your resume.